Treatment outcomes of pregnant women with drug-resistant tuberculosis in Uganda: A retrospective review of 18 cases

High Prevalence of Rifampicin Resistance Associated with Rural Residence and Very Low Bacillary Load among TB/HIV-Coinfected Patients at the National Tuberculosis Treatment Center in Uganda

(2020) Joseph Baruch Baluku et al.   Biomed Research International

Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda

(2020) Samuel Kasozi et al.   PLoS One

Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017

(2019) Denis Okethwangu et al.   BMC INFECTIOUS DISEASES

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

(2019) Payam Nahid et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill

(2018) Aliasgar Esmail et al.   Journal of Thoracic Disease

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis

(2015) Deus Lukoye et al.   BMC PUBLIC HEALTH

Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe

(2015) Kathryn E. Lancaster et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Tuberculosis in pregnancy: an estimate of the global burden of disease

(2014) Jordan Sugarman et al.   Lancet Global Health

Drug‐Resistant Tuberculosis and Pregnancy: Treatment Outcomes of 38 Cases in Lima, Peru

(2009) Eda Palacios et al.   CLINICAL INFECTIOUS DISEASES

Reference Intervals in Healthy Adult Ugandan Blood Donors and Their Impact on Conducting International Vaccine Trials

(2008) Leigh Anne Eller et al.   PLoS One